Does AVALGLUCOSIDASE ALFA Cause Dyspnoea? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Dyspnoea have been filed in association with AVALGLUCOSIDASE ALFA (Nexviazyme). This represents 23.5% of all adverse event reports for AVALGLUCOSIDASE ALFA.
16
Reports of Dyspnoea with AVALGLUCOSIDASE ALFA
23.5%
of all AVALGLUCOSIDASE ALFA reports
0
Deaths
3
Hospitalizations
How Dangerous Is Dyspnoea From AVALGLUCOSIDASE ALFA?
Of the 16 reports, 3 (18.8%) required hospitalization.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVALGLUCOSIDASE ALFA. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does AVALGLUCOSIDASE ALFA Cause?
Thrombocytopenia (13)
Leukopenia (12)
Loss of consciousness (10)
Abdominal discomfort (9)
White blood cell count decreased (9)
Pyrexia (6)
Dizziness (5)
Oxygen saturation decreased (5)
Urticaria (5)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)